嵌入纳米载体的溶解微针的时空空间命运:针溶解速率的影响
Jinghang Cong1,2, Ziyang Zheng1, Yanping Fu1,2
1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
Expert opinion on drug delivery
|July 4, 2024
概括
溶解微针 (DMN) 的溶解速率影响纳米载体 (NC) 在体内命运. 更快溶解的DMN (DMN-HA) 显示出更深的NC扩散,而更慢溶解的DMN (DMN-CS) 则提供了更长的保留时间.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 溶解微针 (DMN) 是通过皮肤递送药物的有希望的方法.
- 将DMN与纳米载体 (NC) 结合起来,可以实现有针对性的交付.
- 了解DMN的溶解速率对于临床转换至关重要.
研究的目的:
- 研究DMN的溶解速率如何影响负载NCs的体内行为.
- 引导NC装载DMN系统的合理设计,以提高药物输送效率.
主要方法:
- 用P4探针标记的固体脂质纳米粒子 (SLN) 作为模型NCs.
- 使用不同溶解速率的氨酸酸 (HA) 和酸盐 (CS) 制造DMN.
- 通过光追踪P4标记的SLN在DMN通过皮肤应用后的体内分布.
主要成果:
- 与缓慢溶解的DMN-CS (140微米) 相比,更快溶解的DMN-HA促进了P4 SLNs (180微米) 的更深的扩散.
- 在DMN-HA中,P4 SLNs在体内半衰期 (T1/2) 较短,为12.14小时.
- 在DMN-CS.中观察到P4 SLNs的更长的保留时间 (13.12小时的T1/2).
结论:
- 负载NC的DMN的体内扩散速率受到DMN材料溶解速率的直接影响.
- 这项研究为优化基于DMN的药物递送系统的设计提供了必要的见解.
- 定制DMN溶解特征可以控制体内NC的命运和保留.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
794
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
794
Factors Influencing Drug Absorption: Drug Dissolution
459
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
459
Non-Oral Extravascular Drug Absorption Routes
209
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
209


